banner

Newsletter

Rise in IPOs Highlight Renewed Interest

Xconomy’s Luke Timmerman captures the rising fortunes of several of the 2013’s IPO class in his most recent article.

With IPOs on the rise again, generalist investors are more active, and there is less of the gloom and doom we’ve been hearing in the previous four years. Timmerman highlights BayBio member Plexxikon, the Berkeley, CA-based company that sold itself to Daiichi Sankyo instead of going public.

“My things have changed,” writes Timmerman. “Everybody in biotech is buzzing now about the revival of the IPO market… In the month of May, eight life science companies went public, the most in any month since 16 life sciences companies arrived on the public markets in August 2000, according to The Burrill Report.”

Read Timmerman’s entire article and a chart on the 2013 IPO class to date here.